News NICE finalises support for CSL's HAE therapy Andembry CSL Behring's Andembry can be used to prevent recurrent attacks of HAE by the NHS, following finalised guidance from reimbursement authority NICE.
News J&J on the hook for $966m damages in latest talc lawsuit Johnson & Johnson has suffered a setback in its long-running legal defence against claims its talc products cause cancer.
News Acting CDC director says MMR jabs should be split The acting director of the CDC, Jim O’Neill, has been sharply criticised after saying the MMR vaccine should be separated into three individual shots.
News Roche gets EU nod for kidney disease algorithm Roche and Klinrisk have picked up a CE-mark for an AI tool that can be used to predict renal function decline in patients with chronic kidney disease.
News GLP-1s from Novo, Lilly 'should be first-line in obesity' European doctors have said GLP-1 drugs are so effective in obesity that they should be the first choice drug treatment in almost all cases.
News FDA angers anti-abortion lobby with generic abortion pill OK The FDA has cleared another generic of the abortion pill mifepristone, as it carries out a review of the drug that has been criticised as spurious.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.